Ning Zou

Wuhan, 430071, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer.

AZD4635 Targets cAMP/CREB Axis to Salvage PARPi-Induced Immune Evasion and Enhance Antitumor Efficacy in Ovarian Cancer.

Journal: Pharmaceutics
Published: January 13, 2026

Comment on "Survival benefit of radiotherapy in pancreatic cancer: a real-world analysis based on SEER and an independent hospital-based cohort".

Comment on "Survival benefit of radiotherapy in pancreatic cancer: a real-world analysis based on SEER and an independent hospital-based cohort".

Journal: International journal of surgery (London, England)
Published: November 21, 2025

Intestinal microbiota affects the progression of colorectal cancer by participating in the host intestinal arginine catabolism.

Intestinal microbiota affects the progression of colorectal cancer by participating in the host intestinal arginine catabolism.

Journal: Cell reports
Published: July 03, 2024

Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.

Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas.

Journal: CNS neuroscience & therapeutics
Published: March 28, 2023

Influence of neo-adjuvant radiotherapy on the intestinal microbiota of rectal cancer patients.

Influence of neo-adjuvant radiotherapy on the intestinal microbiota of rectal cancer patients.

Journal: Journal of cancer research and clinical oncology
Published: November 11, 2022

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients.

Journal: Frontiers in immunology
Published: May 17, 2022

MICAL2 Promotes Proliferation and Migration of Glioblastoma Cells Through TGF-β/p-Smad2/EMT-Like Signaling Pathway.

MICAL2 Promotes Proliferation and Migration of Glioblastoma Cells Through TGF-β/p-Smad2/EMT-Like Signaling Pathway.

Journal: Frontiers in oncology
Published: July 02, 2021

Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report.

Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report.

Journal: Medicine
Published: October 30, 2020

Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity.

Cancer immune checkpoint blockade therapy and its associated autoimmune cardiotoxicity.

Journal: Acta pharmacologica Sinica
Published: March 31, 2018

DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.

DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.

Journal: Cell death & disease
Published: January 15, 2018
Showing 1-10 of 10

Last Updated: 09/26/2026